NCT00561756 2015-11-17Vaccine Therapy in Treating Patients With Recurrent B-Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed8 enrolled
NCT00562068 2013-08-26Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Unknown30 enrolled